Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P08908 (
5-HT1A
)
5,574
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of corticosterone after binding to
5-HT1A
and 5-HT2 receptors were studied in rats. Binding of [3H]8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) to
5-HT1A
receptors in the hippocampus decreased 24 h after both acute and chronic (14 day) administration of
CORT
(50 mg/kg, s.c.). Chronic, but not acute,
CORT
treatment increased [3H]ketanserin binding to 5-HT2 receptors in the frontal cortex. Receptor-mediated behavioral responses were also examined following acute and chronic
CORT
treatment. Flat body posture and hypothermia induced by 8-OH-DPAT, a
5-HT1A
receptor agonist, were attenuated following chronic, but not acute,
CORT
administration. (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT2 receptor agonist, induced wet-dog shakes, but not hyperthermia and this response was increased 24 h after the chronic administration of
CORT
. These findings indicate that both
5-HT1A
and 5-HT2 receptor functions were changed following chronic exposure to high levels of
CORT
. Such changes in these receptor systems may play an important role in the etiology of affective disorders.
...
PMID:Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. 931 24